Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,340.00    -116.00 (-2.60%)
Bid:
4,296.00
Ask:
4,376.00
Spread: 80.00 (1.862%)
Market Cap: £4.55b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Trading Statement

14 Jun 2012 07:00

RNS Number : 3337F
Computacenter PLC
14 June 2012
 

Computacenter plcTrading Update14 June 2012

'Significant new business wins to incur additional start-up costs in 2012'

Computacenter plc, Europe's leading independent provider of IT infrastructure services, today publishes a trading update and outlook for the full year, based on unaudited information.As we stated at the time of our Interim Management Statement on 18 April 2012, Services revenue growth has increased substantially and is likely to have grown in excess of 15% at a Group level, in constant currency, during the first half of 2012. This is clearly an acceleration, compared to the 11% growth rate experienced in the first quarter. As we look forward into the rest of the year, we see no indications that this growth rate will moderate, as it is underpinned by contracts already won, as well as a substantial new business pipeline.We expect that our Supply Chain business will experience high single digit growth for H1 2012 and while there are sectors of challenging market conditions, such as investment banking in the UK and the public sector in France, caused by the uncertainty around the changes in their Government, investment by our customers in capital expenditure projects, remains satisfactory.We are clearly pleased with the substantial Services growth rate, which is testament to the commercial market's appetite for Computacenter's offerings and our track record of excellent execution for our clients. However, it has become apparent to the Board that the significant amount of new business growth requires material investment through our P&L, to deliver successful take-on of the new business and drive high customer satisfaction to underpin Computacenter's success in the years ahead.The take-on cost of this new business includes, but is not limited to, the recruitment of over 700 new Services personnel and the transfer of many staff from customers and their historical suppliers. Clearly, there are material recruitment and training costs for these new starters. Our investment in systems, both back office and customer facing, has also been substantial. Understandably, we are seeing these capital investments increase our depreciation costs. The new business has also attracted significant costs associated to sales commissions, which are predominately paid up-front.These incremental investments to support our future growth are likely to cost Computacenter in the region of an additional £7 million in 2012, compared with our previous expectations. It should also be noted that the depreciation of the euro against sterling, if it were to remain at the current level, would impact Computacenter's profit in 2012 by approximately an additional £3 million.

Mike Norris, CEO of Computacenter said: 'While we highlighted the necessity for investment in our statement of 18 April 2012, both the size and scope of the opportunities we have won have increased significantly, requiring us to invest further.'

Our next scheduled trading update will be the pre-close update prior to our Interim Results, which is scheduled for 17 July 2012.Enquiries:

Computacenter plc:Mike Norris, Chief Executive 01707 631601Tony Conophy, Finance Director 01707 631515Tessa Freeman, PR Manager 01707 631514Tulchan Communications: 020 7353 4200

Christian CowleyRebecca Scott

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFJMLTMBBBBPT
Date   Source Headline
2nd Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSQ3 2022 Trading Update
20th Oct 202210:30 amRNSDirectorate Change
27th Sep 202212:00 pmRNSHolding(s) in Company
22nd Sep 202210:30 amRNSDirector/PDMR Shareholding
12th Sep 202212:00 pmRNSDirector/PDMR Shareholding
9th Sep 20227:00 amRNSHalf-year Report
5th Aug 20229:30 amRNSBlock listing Interim Review
13th Jul 20227:00 amRNSAcquisition
19th May 20221:30 pmRNSResult of AGM
9th May 20225:30 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSQ1 2022 Trading Update
27th Apr 20229:03 amRNSCarbon Neutral Announcement
13th Apr 202212:15 pmRNS2021 Annual Financial Report & Notice of 2022 AGM
23rd Mar 20224:45 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSFinal Results 2021
7th Feb 20229:49 amRNSBlock listing Interim Review
24th Jan 20227:00 amRNSPre-Close Trading Statement
12th Jan 20229:45 amRNSHolding(s) in Company
14th Dec 20214:45 pmRNSHolding(s) in Company
13th Dec 20215:00 pmRNSHolding(s) in Company
10th Dec 20212:00 pmRNSCompany Secretary Change
2nd Dec 20212:45 pmRNSDirector/PDMR Shareholding
15th Nov 202112:15 pmRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSQ3 2021 Trading Update
30th Sep 202112:00 pmRNSDirectorate Change
15th Sep 20214:25 pmRNSDirector/PDMR Shareholding
9th Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSTrading Statement
12th Aug 202112:00 pmRNSDirector Declaration
6th Aug 202111:15 amRNSBlock listing Interim Review
21st Jul 20217:00 amRNSTrading Statement
20th May 20211:00 pmRNSResult of AGM
30th Apr 20217:00 amRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSQ1 2021 Trading Update
20th Apr 20217:00 amRNS2020 Annual Report & Notice of 2021 AGM
24th Mar 20212:00 pmRNSDirector/PDMR Shareholding
16th Mar 20217:00 amRNSFinal Results 2020
10th Mar 20217:00 amRNSDirectorate Change
5th Feb 20211:18 pmRNSBlock listing Interim Review
25th Jan 202111:45 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSPre-Close Trading Statement
4th Jan 20211:00 pmRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSTrading Statement
10th Nov 20204:00 pmRNSPDMR/PCA Shareholding
30th Oct 20207:00 amRNSQ3 2020 Trading Update
27th Oct 20209:30 amRNSDirector/PDMR Shareholding
23rd Oct 20205:45 pmRNSApproval of Arrangement Agreement
16th Sep 202012:45 pmRNSDirector/PDMR Shareholding
15th Sep 20201:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.